Kim Campbell Selected Research

Filgrastim (Neupogen)

1/2021	Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis.
1/2020	Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma.
10/2018	Clinical Outcomes of Treatment with Filgrastim Versus a Filgrastim Biosimilar and Febrile Neutropenia-Associated Costs Among Patients with Nonmyeloid Cancer Undergoing Chemotherapy.
1/2018	Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar.
1/2018	Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
10/2017	Expanded access to cancer treatments from conversion to neutropenia prophylaxis with biosimilar filgrastim-sndz.
10/2017	Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim Campbell Research Topics

Disease

8	Neoplasms (Cancer) 06/2022 - 10/2017
8	Febrile Neutropenia 01/2022 - 01/2018
4	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2019 - 04/2014
3	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2021
3	Chemotherapy-Induced Febrile Neutropenia 08/2020 - 10/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2021 - 01/2020
2	Psoriatic Arthritis 01/2020 - 10/2019
2	Neutropenia 01/2018 - 10/2017
1	Rheumatoid Arthritis 01/2022
1	Experimental Arthritis 01/2022
1	Disease Progression 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	COVID-19 01/2021
1	Fatigue 01/2020
1	Pain (Aches) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Spondylitis 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Necrosis 01/2020
1	Joint Diseases (Joint Disease) 10/2019
1	Skin Diseases (Skin Disease) 10/2019
1	Axial Spondyloarthritis 01/2019
1	Fever (Fevers) 01/2018
1	Infections 01/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2012
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2010

Drug/Important Bio-Agent (IBA)

9	Biosimilar PharmaceuticalsIBA 01/2021 - 10/2017
7	Filgrastim (Neupogen)FDA Link 01/2021 - 10/2017
6	pegfilgrastim (Neulasta)FDA Link 09/2021 - 10/2017
6	Ustekinumab (CNTO 1275)FDA Link 01/2021 - 12/2016
4	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2021 - 01/2018
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 10/2017
3	Interleukin-12 (IL 12)IBA 01/2021 - 12/2016
2	AntigensIBA 01/2022 - 01/2020
2	Interleukin-23 (Interleukin 23)IBA 10/2019 - 04/2014
2	Interleukin-17 (Interleukin 17)IBA 10/2019 - 04/2014
1	Human Growth Hormone (Saizen)FDA LinkGeneric 06/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	EpitopesIBA 01/2022
1	Collagen Type II (Type II Collagen)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	InterferonsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Pharmaceutical PreparationsIBA 08/2020
1	pembrolizumabIBA 08/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	C-Reactive ProteinIBA 10/2019
1	CytokinesIBA 10/2019
1	Etanercept (Enbrel)FDA Link 01/2019
1	HLA-C Antigens (HLA-C)IBA 12/2016
1	guselkumabIBA 04/2014
1	deflazacortIBA 09/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010
1	Prednisone (Sone)FDA LinkGeneric 09/2010

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
6	Therapeutics 06/2022 - 09/2010
1	Immunotherapy 01/2022
1	Injections 01/2020
1	Photopheresis 10/2012
1	Oral Administration 12/2004